What labs are indicated for a patient with suspected polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Suspected Polycythemia

For any patient with suspected polycythemia, immediately order: complete blood count (CBC) with differential, serum erythropoietin (EPO) level, and JAK2 mutation testing. 1, 2 These three tests form the essential diagnostic triad that distinguishes polycythemia vera from secondary causes and guides all subsequent management decisions.

Initial Essential Laboratory Tests

Complete Blood Count with Differential

  • Confirm elevated hemoglobin/hematocrit (>16.5 g/dL in men, >16.0 g/dL in women for polycythemia vera diagnosis) 2
  • Assess for thrombocytosis (present in 53% of polycythemia vera cases) and leukocytosis (present in 49% of cases), as these PV-related features strengthen diagnostic suspicion 2, 3
  • Evaluate mean corpuscular hemoglobin concentration (MCHC) - low values may indicate iron deficiency that can mask erythrocytosis 4
  • Repeat measurements to confirm true polycythemia rather than transient elevation 4

Serum Erythropoietin (EPO) Level

  • **Low EPO (<2 U/L or below reference range)** strongly suggests polycythemia vera with >90% specificity, though sensitivity is only 64-70% 5, 1, 4
  • Normal EPO levels do not exclude polycythemia vera - proceed with JAK2 testing as EPO sensitivity for PV is insufficient to rule out the diagnosis 1, 4
  • Elevated EPO points toward secondary polycythemia and triggers systematic evaluation for hypoxia-driven or hypoxia-independent causes 5, 1
  • Critical pitfall: In chronic hypoxic states (smoker's polycythemia, COPD), EPO may initially be elevated but can normalize once hemoglobin stabilizes at a compensatory higher level, potentially mimicking polycythemia vera 1, 4

JAK2 Mutation Testing

  • JAK2V617F or exon 12 mutations are present in >95% of polycythemia vera patients, making this the most sensitive diagnostic test 2, 6
  • Order immediately alongside EPO level rather than waiting for EPO results, as normal EPO does not exclude PV 4
  • Positive JAK2 with elevated hemoglobin essentially confirms polycythemia vera diagnosis 2, 6

Secondary Laboratory Tests Based on Initial Results

If EPO is Low or Normal with Negative JAK2

  • Bone marrow examination with cytogenetic studies to confirm PV diagnosis through histology showing hypercellularity, increased megakaryocytes with cluster formation, and giant megakaryocytes with pleomorphic morphology 5, 4
  • Specialized testing in equivocal cases (constituting <10% of patients): bone marrow immunohistochemistry for c-mpl (thrombopoietin receptor), neutrophil PRV-1 expression assay, or spontaneous erythroid colony assay 5, 4

If EPO is Elevated - Evaluate for Secondary Polycythemia

Hypoxia-Driven Causes:

  • Arterial blood gas analysis or pulse oximetry to assess for hypoxemia 1
  • Carboxyhemoglobin level if smoking history present (though clinical assessment of smoking status typically sufficient) 1
  • Sleep study for suspected sleep apnea 1
  • Chest X-ray to evaluate for chronic lung disease 1

Hypoxia-Independent Causes:

  • Renal function tests (creatinine, BUN) to screen for kidney disease 1
  • Liver function tests (AST, ALT, bilirubin) to screen for hepatocellular carcinoma 1
  • Abdominal ultrasound or CT to screen for EPO-producing tumors: renal cell carcinoma, hepatocellular carcinoma, uterine leiomyomas, pheochromocytoma 1, 4
  • Review medication history for exogenous erythropoietin or testosterone use 4

Additional Supporting Laboratory Tests

  • Lactate dehydrogenase (LDH) and ESR if suspicion of underlying hematological malignancy with systemic symptoms 1
  • Serum calcium, PTH, and phosphorus if evaluating for parathyroid carcinoma as a rare cause of EPO-producing tumor 1

Critical Diagnostic Pitfalls to Avoid

  • Do not assume normal EPO excludes polycythemia vera - EPO sensitivity for PV is only 64-70%; always proceed with JAK2 testing when hemoglobin is elevated 1, 4
  • Do not perform unnecessary red cell mass measurements - modern JAK2 testing and EPO levels have largely replaced the need for these studies except in truly equivocal cases 5, 1
  • Do not rely on traditional markers alone (splenomegaly, leukocyte alkaline phosphatase, vitamin B12 levels) as these lack both sensitivity and specificity for PV 4
  • Beware of "masked" polycythemia vera - patients with iron deficiency, blood loss, or plasma volume expansion may have normal hemoglobin/hematocrit despite underlying PV; investigate for myeloproliferative neoplasm if unusual site thrombosis occurs even with normal blood counts 7
  • Do not miss smoker's polycythemia - this is a real condition from chronic carbon monoxide exposure that resolves with smoking cessation and is the most common cause of secondary polycythemia 1, 3

Clinical Features That Trigger Immediate Laboratory Workup

  • Sustained hemoglobin increase ≥2 g/dL from baseline, even if within normal reference range 4
  • Unusual thrombosis (Budd-Chiari syndrome, splanchnic vein thrombosis, cerebral venous sinus thrombosis) 4, 2
  • Aquagenic pruritus (itching after water exposure) 4
  • Erythromelalgia (burning pain in extremities with erythema) 4, 2
  • Splenomegaly (present in 36% of PV cases) 2

References

Guideline

Secondary Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.